nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ALB—chronic obstructive pulmonary disease	0.287	1	CbGaD
Methotrexate—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0535	0.338	CbGbCtD
Methotrexate—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0505	0.319	CbGbCtD
Methotrexate—ALB—Prednisone—chronic obstructive pulmonary disease	0.0261	0.165	CbGbCtD
Methotrexate—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0144	0.0914	CbGbCtD
Methotrexate—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0136	0.0863	CbGbCtD
Methotrexate—ATIC—leg—chronic obstructive pulmonary disease	0.0121	0.101	CbGeAlD
Methotrexate—FOLR1—respiratory system—chronic obstructive pulmonary disease	0.00534	0.0444	CbGeAlD
Methotrexate—FOLR1—bronchus—chronic obstructive pulmonary disease	0.00439	0.0365	CbGeAlD
Methotrexate—FOLR1—trachea—chronic obstructive pulmonary disease	0.00394	0.0328	CbGeAlD
Methotrexate—FPGS—respiratory system—chronic obstructive pulmonary disease	0.00312	0.0259	CbGeAlD
Methotrexate—ATIC—respiratory system—chronic obstructive pulmonary disease	0.00302	0.0251	CbGeAlD
Methotrexate—GGH—bronchus—chronic obstructive pulmonary disease	0.00292	0.0243	CbGeAlD
Methotrexate—GGH—smooth muscle tissue—chronic obstructive pulmonary disease	0.00286	0.0237	CbGeAlD
Methotrexate—FOLR1—lung—chronic obstructive pulmonary disease	0.00283	0.0235	CbGeAlD
Methotrexate—FPGS—connective tissue—chronic obstructive pulmonary disease	0.00274	0.0228	CbGeAlD
Methotrexate—ATIC—connective tissue—chronic obstructive pulmonary disease	0.00265	0.0221	CbGeAlD
Methotrexate—GGH—trachea—chronic obstructive pulmonary disease	0.00262	0.0218	CbGeAlD
Methotrexate—FPGS—bronchus—chronic obstructive pulmonary disease	0.00257	0.0213	CbGeAlD
Methotrexate—SLC19A1—lung—chronic obstructive pulmonary disease	0.00249	0.0206	CbGeAlD
Methotrexate—ATIC—smooth muscle tissue—chronic obstructive pulmonary disease	0.00243	0.0202	CbGeAlD
Methotrexate—SLCO4C1—trachea—chronic obstructive pulmonary disease	0.00232	0.0193	CbGeAlD
Methotrexate—FPGS—trachea—chronic obstructive pulmonary disease	0.0023	0.0191	CbGeAlD
Methotrexate—MTHFR—respiratory system—chronic obstructive pulmonary disease	0.00224	0.0186	CbGeAlD
Methotrexate—TYMS—respiratory system—chronic obstructive pulmonary disease	0.00205	0.017	CbGeAlD
Methotrexate—DHFR—respiratory system—chronic obstructive pulmonary disease	0.00203	0.0168	CbGeAlD
Methotrexate—PGD—respiratory system—chronic obstructive pulmonary disease	0.00195	0.0162	CbGeAlD
Methotrexate—GGH—lung—chronic obstructive pulmonary disease	0.00188	0.0156	CbGeAlD
Methotrexate—MTHFR—bronchus—chronic obstructive pulmonary disease	0.00184	0.0153	CbGeAlD
Methotrexate—SLCO3A1—bronchus—chronic obstructive pulmonary disease	0.00182	0.0151	CbGeAlD
Methotrexate—TYMS—connective tissue—chronic obstructive pulmonary disease	0.0018	0.015	CbGeAlD
Methotrexate—DHFR—connective tissue—chronic obstructive pulmonary disease	0.00178	0.0148	CbGeAlD
Methotrexate—PGD—connective tissue—chronic obstructive pulmonary disease	0.00171	0.0142	CbGeAlD
Methotrexate—TYMS—bronchus—chronic obstructive pulmonary disease	0.00168	0.014	CbGeAlD
Methotrexate—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.00168	0.0139	CbGeAlD
Methotrexate—SLCO4C1—lung—chronic obstructive pulmonary disease	0.00167	0.0139	CbGeAlD
Methotrexate—DHFR—bronchus—chronic obstructive pulmonary disease	0.00167	0.0138	CbGeAlD
Methotrexate—FPGS—lung—chronic obstructive pulmonary disease	0.00166	0.0138	CbGeAlD
Methotrexate—TYMS—smooth muscle tissue—chronic obstructive pulmonary disease	0.00165	0.0137	CbGeAlD
Methotrexate—SLCO1B3—lung—chronic obstructive pulmonary disease	0.00162	0.0135	CbGeAlD
Methotrexate—PGD—bronchus—chronic obstructive pulmonary disease	0.0016	0.0133	CbGeAlD
Methotrexate—ATIC—lung—chronic obstructive pulmonary disease	0.0016	0.0133	CbGeAlD
Methotrexate—PGD—smooth muscle tissue—chronic obstructive pulmonary disease	0.00157	0.013	CbGeAlD
Methotrexate—DHFR—trachea—chronic obstructive pulmonary disease	0.0015	0.0124	CbGeAlD
Methotrexate—PGD—trachea—chronic obstructive pulmonary disease	0.00144	0.012	CbGeAlD
Methotrexate—AOX1—bronchus—chronic obstructive pulmonary disease	0.00141	0.0117	CbGeAlD
Methotrexate—ABCC10—bronchus—chronic obstructive pulmonary disease	0.00137	0.0114	CbGeAlD
Methotrexate—AOX1—trachea—chronic obstructive pulmonary disease	0.00127	0.0105	CbGeAlD
Methotrexate—ABCC10—trachea—chronic obstructive pulmonary disease	0.00123	0.0103	CbGeAlD
Methotrexate—MTHFR—lung—chronic obstructive pulmonary disease	0.00119	0.00989	CbGeAlD
Methotrexate—SLCO3A1—lung—chronic obstructive pulmonary disease	0.00117	0.00973	CbGeAlD
Methotrexate—ABCC4—bronchus—chronic obstructive pulmonary disease	0.00114	0.00947	CbGeAlD
Methotrexate—TYMS—lung—chronic obstructive pulmonary disease	0.00109	0.00902	CbGeAlD
Methotrexate—DHFR—lung—chronic obstructive pulmonary disease	0.00108	0.00894	CbGeAlD
Methotrexate—PGD—lung—chronic obstructive pulmonary disease	0.00103	0.00859	CbGeAlD
Methotrexate—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000972	0.00807	CbGeAlD
Methotrexate—SLC16A1—lung—chronic obstructive pulmonary disease	0.000965	0.00802	CbGeAlD
Methotrexate—AOX1—lung—chronic obstructive pulmonary disease	0.000911	0.00757	CbGeAlD
Methotrexate—ABCC3—lung—chronic obstructive pulmonary disease	0.000891	0.0074	CbGeAlD
Methotrexate—ABCC10—lung—chronic obstructive pulmonary disease	0.000886	0.00737	CbGeAlD
Methotrexate—ABCC1—trachea—chronic obstructive pulmonary disease	0.000873	0.00725	CbGeAlD
Methotrexate—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000764	0.00635	CbGeAlD
Methotrexate—ABCC4—lung—chronic obstructive pulmonary disease	0.000735	0.00611	CbGeAlD
Methotrexate—ABCC1—lung—chronic obstructive pulmonary disease	0.000627	0.00521	CbGeAlD
Methotrexate—ABCG2—lung—chronic obstructive pulmonary disease	0.000519	0.00431	CbGeAlD
Methotrexate—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000482	0.00401	CbGeAlD
Methotrexate—ABCB1—trachea—chronic obstructive pulmonary disease	0.000356	0.00296	CbGeAlD
Methotrexate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00122	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.00121	CcSEcCtD
Methotrexate—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000337	0.00121	CcSEcCtD
Methotrexate—Cough—Formoterol—chronic obstructive pulmonary disease	0.000337	0.00121	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.000334	0.1	CbGdCrCtD
Methotrexate—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000332	0.00119	CcSEcCtD
Methotrexate—Cough—Montelukast—chronic obstructive pulmonary disease	0.00033	0.00119	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00033	0.0992	CbGdCrCtD
Methotrexate—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00118	CcSEcCtD
Methotrexate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00118	CcSEcCtD
Methotrexate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00118	CcSEcCtD
Methotrexate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000327	0.00118	CcSEcCtD
Methotrexate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000327	0.00118	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.000327	0.0982	CbGdCrCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00117	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00117	CcSEcCtD
Methotrexate—TYMS—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.0981	CbGdCrCtD
Methotrexate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00117	CcSEcCtD
Methotrexate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00117	CcSEcCtD
Methotrexate—TYMS—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.0968	CbGdCrCtD
Methotrexate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00116	CcSEcCtD
Methotrexate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000322	0.00116	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00115	CcSEcCtD
Methotrexate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.00115	CcSEcCtD
Methotrexate—TYMS—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.0958	CbGdCrCtD
Methotrexate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00114	CcSEcCtD
Methotrexate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000315	0.00113	CcSEcCtD
Methotrexate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000315	0.00113	CcSEcCtD
Methotrexate—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000314	0.00113	CcSEcCtD
Methotrexate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00112	CcSEcCtD
Methotrexate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00112	CcSEcCtD
Methotrexate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00112	CcSEcCtD
Methotrexate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00112	CcSEcCtD
Methotrexate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00112	CcSEcCtD
Methotrexate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.00111	CcSEcCtD
Methotrexate—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00111	CcSEcCtD
Methotrexate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00111	CcSEcCtD
Methotrexate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00111	CcSEcCtD
Methotrexate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.00111	CcSEcCtD
Methotrexate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00111	CcSEcCtD
Methotrexate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.0011	CcSEcCtD
Methotrexate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000307	0.0011	CcSEcCtD
Methotrexate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000306	0.0011	CcSEcCtD
Methotrexate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.0011	CcSEcCtD
Methotrexate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000305	0.0011	CcSEcCtD
Methotrexate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00109	CcSEcCtD
Methotrexate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000302	0.00109	CcSEcCtD
Methotrexate—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00108	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000301	0.0905	CbGdCrCtD
Methotrexate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00108	CcSEcCtD
Methotrexate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00107	CcSEcCtD
Methotrexate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00106	CcSEcCtD
Methotrexate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.00106	CcSEcCtD
Methotrexate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000295	0.00106	CcSEcCtD
Methotrexate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.00106	CcSEcCtD
Methotrexate—TYMS—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.0883	CbGdCrCtD
Methotrexate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000293	0.00105	CcSEcCtD
Methotrexate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00105	CcSEcCtD
Methotrexate—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000292	0.00105	CcSEcCtD
Methotrexate—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00104	CcSEcCtD
Methotrexate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00104	CcSEcCtD
Methotrexate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000288	0.00103	CcSEcCtD
Methotrexate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00103	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00103	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00103	CcSEcCtD
Methotrexate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00102	CcSEcCtD
Methotrexate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00102	CcSEcCtD
Methotrexate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000284	0.00102	CcSEcCtD
Methotrexate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.00102	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00101	CcSEcCtD
Methotrexate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00101	CcSEcCtD
Methotrexate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00101	CcSEcCtD
Methotrexate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00101	CcSEcCtD
Methotrexate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00101	CcSEcCtD
Methotrexate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000279	0.001	CcSEcCtD
Methotrexate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000999	CcSEcCtD
Methotrexate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000277	0.000997	CcSEcCtD
Methotrexate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.000997	CcSEcCtD
Methotrexate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000277	0.000996	CcSEcCtD
Methotrexate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.000993	CcSEcCtD
Methotrexate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000274	0.000986	CcSEcCtD
Methotrexate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.000984	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000978	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000978	CcSEcCtD
Methotrexate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000272	0.000976	CcSEcCtD
Methotrexate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000976	CcSEcCtD
Methotrexate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000976	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.000974	CcSEcCtD
Methotrexate—Pain—Formoterol—chronic obstructive pulmonary disease	0.00027	0.000968	CcSEcCtD
Methotrexate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.000968	CcSEcCtD
Methotrexate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.000967	CcSEcCtD
Methotrexate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00096	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000957	CcSEcCtD
Methotrexate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000266	0.000956	CcSEcCtD
Methotrexate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.000953	CcSEcCtD
Methotrexate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00095	CcSEcCtD
Methotrexate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000264	0.000948	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.000264	0.0793	CbGdCrCtD
Methotrexate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.000946	CcSEcCtD
Methotrexate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.000941	CcSEcCtD
Methotrexate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.000938	CcSEcCtD
Methotrexate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.000937	CcSEcCtD
Methotrexate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.000935	CcSEcCtD
Methotrexate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.000933	CcSEcCtD
Methotrexate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00026	0.000933	CcSEcCtD
Methotrexate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.000932	CcSEcCtD
Methotrexate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.000929	CcSEcCtD
Methotrexate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.000928	CcSEcCtD
Methotrexate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000258	0.000926	CcSEcCtD
Methotrexate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.000926	CcSEcCtD
Methotrexate—TYMS—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.0774	CbGdCrCtD
Methotrexate—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000925	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000923	CcSEcCtD
Methotrexate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000922	CcSEcCtD
Methotrexate—ABCB1—lung—chronic obstructive pulmonary disease	0.000256	0.00213	CbGeAlD
Methotrexate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.000914	CcSEcCtD
Methotrexate—TYMS—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000253	0.076	CbGdCrCtD
Methotrexate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000252	0.000907	CcSEcCtD
Methotrexate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000252	0.000907	CcSEcCtD
Methotrexate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.000899	CcSEcCtD
Methotrexate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00025	0.000899	CcSEcCtD
Methotrexate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000249	0.000895	CcSEcCtD
Methotrexate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.000895	CcSEcCtD
Methotrexate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000249	0.000895	CcSEcCtD
Methotrexate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.000895	CcSEcCtD
Methotrexate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.000892	CcSEcCtD
Methotrexate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.000885	CcSEcCtD
Methotrexate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.000884	CcSEcCtD
Methotrexate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000246	0.000884	CcSEcCtD
Methotrexate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000245	0.000881	CcSEcCtD
Methotrexate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.000881	CcSEcCtD
Methotrexate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.000879	CcSEcCtD
Methotrexate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000244	0.000877	CcSEcCtD
Methotrexate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000244	0.000877	CcSEcCtD
Methotrexate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.000874	CcSEcCtD
Methotrexate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000867	CcSEcCtD
Methotrexate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000865	CcSEcCtD
Methotrexate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.000863	CcSEcCtD
Methotrexate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000859	CcSEcCtD
Methotrexate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000849	CcSEcCtD
Methotrexate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.000845	CcSEcCtD
Methotrexate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.000845	CcSEcCtD
Methotrexate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000232	0.000834	CcSEcCtD
Methotrexate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.000834	CcSEcCtD
Methotrexate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000232	0.000833	CcSEcCtD
Methotrexate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.000832	CcSEcCtD
Methotrexate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000227	0.000817	CcSEcCtD
Methotrexate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.000812	CcSEcCtD
Methotrexate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000226	0.000812	CcSEcCtD
Methotrexate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.000801	CcSEcCtD
Methotrexate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000223	0.000801	CcSEcCtD
Methotrexate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000796	CcSEcCtD
Methotrexate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.000788	CcSEcCtD
Methotrexate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000785	CcSEcCtD
Methotrexate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000775	CcSEcCtD
Methotrexate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000775	CcSEcCtD
Methotrexate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000768	CcSEcCtD
Methotrexate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000767	CcSEcCtD
Methotrexate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000759	CcSEcCtD
Methotrexate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.000756	CcSEcCtD
Methotrexate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000751	CcSEcCtD
Methotrexate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.000749	CcSEcCtD
Methotrexate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000208	0.000749	CcSEcCtD
Methotrexate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000204	0.000733	CcSEcCtD
Methotrexate—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000733	CcSEcCtD
Methotrexate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000731	CcSEcCtD
Methotrexate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000722	CcSEcCtD
Methotrexate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00072	CcSEcCtD
Methotrexate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00072	CcSEcCtD
Methotrexate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.000714	CcSEcCtD
Methotrexate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000199	0.000714	CcSEcCtD
Methotrexate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000199	0.000713	CcSEcCtD
Methotrexate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.000713	CcSEcCtD
Methotrexate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000197	0.000709	CcSEcCtD
Methotrexate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.000709	CcSEcCtD
Methotrexate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000708	CcSEcCtD
Methotrexate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000707	CcSEcCtD
Methotrexate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000196	0.000705	CcSEcCtD
Methotrexate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000195	0.000699	CcSEcCtD
Methotrexate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000195	0.000699	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000697	CcSEcCtD
Methotrexate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000697	CcSEcCtD
Methotrexate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000193	0.000695	CcSEcCtD
Methotrexate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00068	CcSEcCtD
Methotrexate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000678	CcSEcCtD
Methotrexate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.000675	CcSEcCtD
Methotrexate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000674	CcSEcCtD
Methotrexate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000673	CcSEcCtD
Methotrexate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.000673	CcSEcCtD
Methotrexate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000187	0.000673	CcSEcCtD
Methotrexate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00067	CcSEcCtD
Methotrexate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000183	0.000659	CcSEcCtD
Methotrexate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000651	CcSEcCtD
Methotrexate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000635	CcSEcCtD
Methotrexate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000632	CcSEcCtD
Methotrexate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000176	0.00063	CcSEcCtD
Methotrexate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000627	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.000613	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000593	CcSEcCtD
Methotrexate—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000586	CcSEcCtD
Methotrexate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000569	CcSEcCtD
Methotrexate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000567	CcSEcCtD
Methotrexate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000555	CcSEcCtD
Methotrexate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000554	CcSEcCtD
Methotrexate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000551	CcSEcCtD
Methotrexate—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000549	CcSEcCtD
Methotrexate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000546	CcSEcCtD
Methotrexate—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000546	CcSEcCtD
Methotrexate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000524	CcSEcCtD
Methotrexate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000515	CcSEcCtD
Methotrexate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000507	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000505	CcSEcCtD
Methotrexate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000505	CcSEcCtD
Methotrexate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000492	CcSEcCtD
Methotrexate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000491	CcSEcCtD
Methotrexate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000487	CcSEcCtD
Methotrexate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000473	CcSEcCtD
Methotrexate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000465	CcSEcCtD
Methotrexate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000465	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000462	CcSEcCtD
Methotrexate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000459	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000452	CcSEcCtD
Methotrexate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000446	CcSEcCtD
Methotrexate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000443	CcSEcCtD
Methotrexate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000437	CcSEcCtD
Methotrexate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000433	CcSEcCtD
Methotrexate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000431	CcSEcCtD
Methotrexate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000425	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000406	CcSEcCtD
Methotrexate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000405	CcSEcCtD
Methotrexate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000403	CcSEcCtD
Methotrexate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.0004	CcSEcCtD
Methotrexate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000392	CcSEcCtD
Methotrexate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000387	CcSEcCtD
Methotrexate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000387	CcSEcCtD
Methotrexate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000386	CcSEcCtD
Methotrexate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000384	CcSEcCtD
Methotrexate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000384	CcSEcCtD
Methotrexate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000367	CcSEcCtD
Methotrexate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000364	CcSEcCtD
Methotrexate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000364	CcSEcCtD
Methotrexate—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000354	CcSEcCtD
Methotrexate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.000352	CcSEcCtD
Methotrexate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.000352	CcSEcCtD
Methotrexate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.14e-05	0.000328	CcSEcCtD
Methotrexate—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.00032	CcSEcCtD
Methotrexate—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.78e-05	0.000315	CcSEcCtD
Methotrexate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000305	CcSEcCtD
Methotrexate—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000295	CcSEcCtD
Methotrexate—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000283	CcSEcCtD
Methotrexate—Rash—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000281	CcSEcCtD
Methotrexate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000281	CcSEcCtD
Methotrexate—Headache—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000279	CcSEcCtD
Methotrexate—Nausea—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000265	CcSEcCtD
Methotrexate—SLC16A1—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.66e-05	0.000305	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.65e-05	0.000305	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NOS3—chronic obstructive pulmonary disease	4.62e-05	0.000303	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.61e-05	0.000302	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—TGFB1—chronic obstructive pulmonary disease	4.61e-05	0.000302	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.61e-05	0.000302	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.56e-05	0.000299	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GCLC—chronic obstructive pulmonary disease	4.56e-05	0.000299	CbGpPWpGaD
Methotrexate—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.55e-05	0.000298	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—EGFR—chronic obstructive pulmonary disease	4.52e-05	0.000296	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.5e-05	0.000295	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.48e-05	0.000293	CbGpPWpGaD
Methotrexate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	4.46e-05	0.000292	CbGpPWpGaD
Methotrexate—PGD—Disease—SERPINE1—chronic obstructive pulmonary disease	4.42e-05	0.00029	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.41e-05	0.000289	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.39e-05	0.000288	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.38e-05	0.000287	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.36e-05	0.000286	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.36e-05	0.000286	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.34e-05	0.000284	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.33e-05	0.000284	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.33e-05	0.000284	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.32e-05	0.000283	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.3e-05	0.000282	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.23e-05	0.000277	CbGpPWpGaD
Methotrexate—PGD—Disease—NOS3—chronic obstructive pulmonary disease	4.22e-05	0.000277	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.22e-05	0.000276	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.18e-05	0.000274	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CTGF—chronic obstructive pulmonary disease	4.16e-05	0.000272	CbGpPWpGaD
Methotrexate—MTHFR—Disease—ERBB3—chronic obstructive pulmonary disease	4.16e-05	0.000272	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.15e-05	0.000272	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.12e-05	0.00027	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.06e-05	0.000266	CbGpPWpGaD
Methotrexate—AOX1—Disease—ERBB3—chronic obstructive pulmonary disease	4.06e-05	0.000266	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.05e-05	0.000266	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.04e-05	0.000265	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.04e-05	0.000265	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.02e-05	0.000264	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.02e-05	0.000264	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4e-05	0.000262	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4e-05	0.000262	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.97e-05	0.00026	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.93e-05	0.000258	CbGpPWpGaD
Methotrexate—FPGS—Disease—TGFB1—chronic obstructive pulmonary disease	3.92e-05	0.000257	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.9e-05	0.000256	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.9e-05	0.000255	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.87e-05	0.000253	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.85e-05	0.000252	CbGpPWpGaD
Methotrexate—FPGS—Disease—EGFR—chronic obstructive pulmonary disease	3.84e-05	0.000252	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.84e-05	0.000252	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.83e-05	0.000251	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.82e-05	0.00025	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.81e-05	0.00025	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.79e-05	0.000248	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.77e-05	0.000247	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.76e-05	0.000246	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.75e-05	0.000246	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.71e-05	0.000243	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—chronic obstructive pulmonary disease	3.7e-05	0.000242	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.7e-05	0.000242	CbGpPWpGaD
Methotrexate—DHFR—Disease—ERBB3—chronic obstructive pulmonary disease	3.69e-05	0.000242	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.66e-05	0.00024	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.64e-05	0.000238	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	3.63e-05	0.000238	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.61e-05	0.000237	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.59e-05	0.000235	CbGpPWpGaD
Methotrexate—PGD—Metabolism—NOS3—chronic obstructive pulmonary disease	3.54e-05	0.000232	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.52e-05	0.00023	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.51e-05	0.00023	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.51e-05	0.00023	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—chronic obstructive pulmonary disease	3.47e-05	0.000228	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.47e-05	0.000228	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS2—chronic obstructive pulmonary disease	3.47e-05	0.000227	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.44e-05	0.000226	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS2—chronic obstructive pulmonary disease	3.39e-05	0.000222	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.36e-05	0.000221	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.36e-05	0.000221	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.36e-05	0.00022	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.34e-05	0.000219	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.33e-05	0.000219	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.32e-05	0.000218	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.29e-05	0.000216	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.29e-05	0.000215	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.28e-05	0.000215	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.28e-05	0.000215	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.19e-05	0.000209	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.19e-05	0.000209	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.000209	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.17e-05	0.000208	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.17e-05	0.000208	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.15e-05	0.000207	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.14e-05	0.000206	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.08e-05	0.000202	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS2—chronic obstructive pulmonary disease	3.08e-05	0.000202	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.06e-05	0.000201	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.06e-05	0.000201	CbGpPWpGaD
Methotrexate—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.05e-05	0.0002	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFB1—chronic obstructive pulmonary disease	3.05e-05	0.0002	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.03e-05	0.000199	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.000199	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	3e-05	0.000197	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3e-05	0.000196	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—EGFR—chronic obstructive pulmonary disease	2.99e-05	0.000196	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.99e-05	0.000196	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.97e-05	0.000195	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.95e-05	0.000194	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—chronic obstructive pulmonary disease	2.95e-05	0.000194	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.94e-05	0.000192	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.93e-05	0.000192	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SERPINE1—chronic obstructive pulmonary disease	2.92e-05	0.000191	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.91e-05	0.000191	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.91e-05	0.00019	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.89e-05	0.000189	CbGpPWpGaD
Methotrexate—AOX1—Disease—SERPINE1—chronic obstructive pulmonary disease	2.85e-05	0.000187	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.84e-05	0.000186	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.81e-05	0.000184	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—chronic obstructive pulmonary disease	2.79e-05	0.000183	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KL—chronic obstructive pulmonary disease	2.79e-05	0.000183	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NOS3—chronic obstructive pulmonary disease	2.79e-05	0.000183	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.78e-05	0.000182	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.76e-05	0.000181	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.76e-05	0.000181	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.76e-05	0.000181	CbGpPWpGaD
Methotrexate—PGD—Disease—EGFR—chronic obstructive pulmonary disease	2.74e-05	0.000179	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.74e-05	0.000179	CbGpPWpGaD
Methotrexate—AOX1—Disease—NOS3—chronic obstructive pulmonary disease	2.72e-05	0.000178	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.7e-05	0.000177	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.69e-05	0.000177	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.68e-05	0.000175	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.65e-05	0.000174	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.64e-05	0.000173	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.63e-05	0.000172	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—TP53—chronic obstructive pulmonary disease	2.63e-05	0.000172	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.62e-05	0.000172	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.62e-05	0.000172	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.61e-05	0.000171	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.6e-05	0.000171	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.6e-05	0.00017	CbGpPWpGaD
Methotrexate—DHFR—Disease—SERPINE1—chronic obstructive pulmonary disease	2.59e-05	0.00017	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.56e-05	0.000168	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.55e-05	0.000167	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TP53—chronic obstructive pulmonary disease	2.54e-05	0.000166	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.5e-05	0.000164	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.49e-05	0.000163	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.000163	CbGpPWpGaD
Methotrexate—DHFR—Disease—NOS3—chronic obstructive pulmonary disease	2.48e-05	0.000162	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—chronic obstructive pulmonary disease	2.44e-05	0.00016	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.000159	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.42e-05	0.000159	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—chronic obstructive pulmonary disease	2.38e-05	0.000156	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.37e-05	0.000156	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.37e-05	0.000155	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.36e-05	0.000155	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—NOS3—chronic obstructive pulmonary disease	2.33e-05	0.000153	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.31e-05	0.000151	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.000151	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.3e-05	0.000151	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—chronic obstructive pulmonary disease	2.3e-05	0.000151	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.3e-05	0.000151	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—TP53—chronic obstructive pulmonary disease	2.29e-05	0.00015	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.28e-05	0.000149	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.27e-05	0.000149	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000144	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.2e-05	0.000144	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.000143	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.17e-05	0.000142	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—chronic obstructive pulmonary disease	2.17e-05	0.000142	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.16e-05	0.000142	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.13e-05	0.000139	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.12e-05	0.000139	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—chronic obstructive pulmonary disease	2.1e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	2.09e-05	0.000137	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.08e-05	0.000136	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—NOS3—chronic obstructive pulmonary disease	2.07e-05	0.000136	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.000136	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.04e-05	0.000134	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.02e-05	0.000132	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.01e-05	0.000131	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.99e-05	0.00013	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.97e-05	0.000129	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.97e-05	0.000129	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.96e-05	0.000128	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.95e-05	0.000128	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.94e-05	0.000127	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.9e-05	0.000125	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—chronic obstructive pulmonary disease	1.89e-05	0.000124	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.89e-05	0.000124	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000124	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.85e-05	0.000122	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—chronic obstructive pulmonary disease	1.84e-05	0.000121	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.82e-05	0.000119	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—chronic obstructive pulmonary disease	1.81e-05	0.000119	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.81e-05	0.000119	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EGFR—chronic obstructive pulmonary disease	1.81e-05	0.000118	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.81e-05	0.000118	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—chronic obstructive pulmonary disease	1.8e-05	0.000118	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.8e-05	0.000118	CbGpPWpGaD
Methotrexate—AOX1—Disease—EGFR—chronic obstructive pulmonary disease	1.76e-05	0.000116	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.74e-05	0.000114	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	1.74e-05	0.000114	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.72e-05	0.000112	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.68e-05	0.00011	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.66e-05	0.000109	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.65e-05	0.000108	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—chronic obstructive pulmonary disease	1.64e-05	0.000107	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.63e-05	0.000107	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.62e-05	0.000106	CbGpPWpGaD
Methotrexate—DHFR—Disease—EGFR—chronic obstructive pulmonary disease	1.61e-05	0.000105	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.6e-05	0.000105	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000104	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.57e-05	0.000103	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	0.000103	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	9.82e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.47e-05	9.62e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.46e-05	9.6e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	9.32e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	9.21e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.4e-05	9.19e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—chronic obstructive pulmonary disease	1.39e-05	9.1e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.36e-05	8.94e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—chronic obstructive pulmonary disease	1.36e-05	8.89e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.35e-05	8.84e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.3e-05	8.55e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	8.41e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.25e-05	8.17e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—chronic obstructive pulmonary disease	1.23e-05	8.09e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.23e-05	8.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	7.75e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.17e-05	7.69e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-05	7.64e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.13e-05	7.42e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.13e-05	7.37e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	7.31e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.11e-05	7.27e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	7.08e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.04e-05	6.81e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.03e-05	6.78e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	6.77e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.86e-06	6.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.8e-06	6.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.72e-06	6.37e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	9.27e-06	6.07e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	9.09e-06	5.96e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.06e-06	5.94e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.59e-06	5.63e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.56e-06	5.61e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	6.98e-06	4.58e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.37e-06	4.18e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.84e-06	3.83e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.58e-06	3.66e-05	CbGpPWpGaD
